ISPOR 2025 in Montréal

Three panels. One great city. Can’t wait for the conversations at ISPOR 2024 in Montréal. GCEA: Where do we go from here? (14 May, 5-6pm)Should we finally rethink the 3% discount rate? (15 May, 3:15-4:15pm)How can HEOR support providers in value-based care? (16 May, 10-11am)  I’ll be diving into all three — including teaming up with…

Read More

Glen Tullman, Transcarent

A couple of weeks back Transcarent completed its $630m acquisition of Accolade. But CEO Glen Tullman calls it a merger for a reason because Accolade brings people, products and clients that Transcarent didn’t have. Glen got in deep about Transcarent’s new product set in terms of its AI fueled navigation, primary care, weight management, cancer…

Read More

What Do Early Stage Life Science Companies Need to Grow?

[Sponsored] Scheduled for May 8 at 1 pm ET, the conversation will include Morgan Cheatham, head of healthcare and life sciences at Breyer Capital, Gurdane Bhutani,  founder and managing partner of MBX Capital, and will be moderated by Mercury Head of Healthcare and Life Sciences Ben Kromnick. The post What Do Early Stage Life Science…

Read More